PHARMAVAX GHANA PROGRAMME REAFFIRMS SUPPORT FOR KCCR AND STRENGTHENS COLLABORATION

PHARMAVAX GHANA PROGRAMME REAFFIRMS SUPPORT FOR KCCR AND STRENGTHENS COLLABORATION

September 1, 2026

The Kumasi Centre for Collaborative Research in Tropical Medicine (KCCR) welcomed a delegation from the PharmaVax Ghana Programme in a visit aimed at congratulating Prof. Alexander Yaw Debrah on assuming office as KCCR’s Scientific Director, reaffirming the program’s support, and further strengthening collaboration between the two institutions.

The delegation was led by Dr. Holger Till, Head of the PharmaVax Ghana Programme, who reiterated the programme’s commitment to advancing joint research and capacity development initiatives with KCCR.

The engagement provided an opportunity for both institutions to reaffirm their shared commitment to strengthening research capacity and supporting initiatives that contribute to improved health outcomes in Ghana and beyond.

The visiting delegation is comprised of Dr. Holger Till: Head of the PharmaVax Ghana Programme, Viktor Siebert: Component Manager, Jasper Sablah: Component Manager, Dr. Vera Serwaa Opoku: Technical Advisor

KCCR appreciates the continued support and partnership of the PharmaVax Ghana Programme and looks forward to deepening collaboration in research, innovation, and capacity development.

The PharmaVax Ghana Programme is co-financed by the European Union (EU) and the German Federal Ministry for Economic Cooperation and Development (BMZ) under the Team Europe Initiative on Manufacturing and Access to Vaccines, Medicines and Health Technologies in Africa (MAV+). It is implemented by Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ).

KCCR / ASAAP Newsletters

Recent News

KCCR’S IDERG SECURES GRANT TO ADVANCE NOVEL ANTIMALARIAL DRUG WITH POTENTIAL TO REDUCE MALARIA TRANSMISSION

September 1, 2026

PHARMAVAX GHANA PROGRAMME REAFFIRMS SUPPORT FOR KCCR AND STRENGTHENS COLLABORATION

September 1, 2026

KCCR CONGRATULATES PROF. YAW AMPEM AMOAKO ON APPOINTMENT AS MEDICAL DIRECTOR OF KATH

September 1, 2026